Migrastatics—Anti-metastatic and Anti-invasion Drugs: Promises and Challenges

Aneta Gandalovičová,Daniel Rosel,Michael Fernandes,P. Veselý,P. Heneberg,V. Čermák,L. Petruželka,Sunil Kumar,V. Sanz-Moreno,J. Brábek

Published 2017 in Trends in Cancer

ABSTRACT

In solid cancers, invasion and metastasis account for more than 90% of mortality. However, in the current armory of anticancer therapies, a specific category of anti-invasion and antimetastatic drugs is missing. Here, we coin the term ‘migrastatics’ for drugs interfering with all modes of cancer cell invasion and metastasis, to distinguish this class from conventional cytostatic drugs, which are mainly directed against cell proliferation. We define actin polymerization and contractility as target mechanisms for migrastatics, and review candidate migrastatic drugs. Critical assessment of these antimetastatic agents is warranted, because they may define new options for the treatment of solid cancers.

PUBLICATION RECORD

CITATION MAP

EXTRACTION MAP

CLAIMS

  • No claims are published for this paper.

CONCEPTS

  • No concepts are published for this paper.

REFERENCES

Showing 1-100 of 148 references · Page 1 of 2

CITED BY

Showing 1-100 of 331 citing papers · Page 1 of 4